This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Regenxbio Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovations of Stephen Yoo
Introduction
Stephen Yoo is an accomplished inventor based in Newton, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of rare genetic disorders. His innovative work has led to the development of a patent that addresses a critical health issue.
Latest Patents
Stephen Yoo holds a patent for the "Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS) produced by human neural or glial cells." This patent describes compositions and methods for delivering recombinant human iduronate-2-sulfatase (IDS) to the cerebrospinal fluid of the central nervous system (CNS) in individuals diagnosed with mucopolysaccharidosis II (MPS II). This groundbreaking work has the potential to improve the quality of life for patients suffering from this condition.
Career Highlights
Stephen Yoo's career is marked by his dedication to advancing medical science. He has been instrumental in developing therapies that target complex diseases. His work at Regenxbio Inc. showcases his commitment to innovation and improving patient outcomes.
Collaborations
Stephen has collaborated with notable colleagues, including Rickey Robert Reinhardt and Curran Matthew Simpson. These partnerships have fostered an environment of creativity and innovation, leading to advancements in their respective fields.
Conclusion
In summary, Stephen Yoo is a prominent inventor whose work in the treatment of mucopolysaccharidosis II has made a significant impact in the medical field. His contributions continue to inspire advancements in healthcare and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile